HDAC9 and lymphoma: The introduction of a larger tricyclic hydrophobic ‘cap’ to the structure of Vorinostat in the place of the phenyl group was beneficial for biological properties and allowed for the development of compounds with improved HDAC inhibition, stronger cytotoxic effects, and higher selectivity against leukemia and lymphoma cell lines.